Stock screener

EBS

Conviction 4HealthcareScan · Mon, Jul 20, 2026
EBS$7.69+0.79%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
6
Vol MA14 785.73K
Apr 20May 6May 26Jun 11Jul 1Jul 20
Emergent BioSolutions Inc.PHARMACEUTICAL PREPARATIONSwww.emergentbiosolutions.com
Price7.69
Change+0.79%
Gap+0.26%
Rel volume0.99×
Avg volume903.73K
Avg $ vol7.29M
SMA 208.07
SMA 508.28
SMA 2009.70
Price vs 50-7.09%
Price vs 200-20.73%
MA stackbearish
50/200 cross
Supertrenddown · 8.63
RSI (14)43
MACD hist-0.05
MACD crossbear · 6d
Stoch %K / %D24 / 23
ADX (14)22
+DI / −DI12 / 25
RSI divergence
MACD divergence
ATR %+4.73%
ADR %4.36%
52w high13.90
52w low5.63
From 52w high-44.68%
Above 52w low+36.59%
New 52w highNo
SqueezeOff
Bollinger width14.27%
%B0.17
Donchian pos24.19%
Donchian high8.63
Donchian low7.39
AVWAP (52w high)9.15
vs AVWAP high-15.94%
AVWAP (52w low)9.51
vs AVWAP low-19.15%
OBV trendDown
Chaikin MF (20)0.01
Today vs 20d0.99×
Avg vol (14d)785.73K
Avg vol (20d)903.73K
Avg $ vol (20d)7.29M
Market cap396.78M
RS 3m (vs SPY)-17.42%
RS 6m (vs SPY)-46.82%
RS line new highNo
Trend template1/8
Technical rank18.7
1 week-4.00%
1 month-5.53%
3 months-12.71%
6 months-29.77%
1 year+5.63%
YTD-38.53%
P/E7.54
P/B0.76
P/S0.53
P/FCF2.53
EPS0.9300
Div yield
ROE10.06%
ROA3.98%
Debt/Eq1.10
Current4.29
EV/EBITDA4.14
Gross margin42.75%
Net margin7.08%
Rev growth-28.81%
EPS growth127.60%
Price target12.00
Target upside56.05%
Analyst ratingBuy
Institutional91.92%
Ent. value810.08M
Revenue156.1M
Net income6.8M
Gross profit161.2M
Free cash flow156.8M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out51.6M
Employees900
ListedWed, Nov 15, 2006
Free float50.61M
Float %98.0%
Short interest10.27M
Days to cover8.0d
Short volume54.6%
Squeeze score75 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction4 / 100
Pattern quality
Tech rank18.7 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance9.02
Support7.48
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EBS · 1 recent

All disclosures →
MemberSideAmount
Steve Cohen
Steve Cohen
house · D · TN · traded 2024-12-11
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in EBS · 10 sells

InsiderSideShares
Hartzel William
SVP, Bioservices · Common Stock · 2026-06-08
Tax1.74K
Williams Paul Anthony
SVP, Products Business · Common Stock · 2026-06-08
Tax694
LINDAHL RICHARD S
EVP, Chief Financial Officer · Common Stock · 2026-06-08
Tax3.96K
Glessner Coleen
EVP, Quality & Ethics, and CPL · Common Stock · 2026-06-08
Tax2.02K
Dayal Sujata Tyagi
Director · Common Stock · 2026-05-01
Sell980
Dayal Sujata Tyagi
Director · Common Stock · 2026-05-01
Sell12.78K
DeGolyer Donald W
Director · Common Stock · 2026-05-01
Sell954
DeGolyer Donald W
Director · Common Stock · 2026-05-01
Sell14.53K
Zoon Kathryn C
Director · Common Stock · 2026-05-01
Sell16.14K
Zoon Kathryn C
Director · Common Stock · 2026-05-01
Sell1.06K

SEC filings

EDGAR filings in EBS · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.